Navigation Links
Abbott Invests Additional $20M in Isis' Subsidiary Ibis Biosciences
Date:7/1/2008

or use in diagnostic procedures. It is capable of identifying virtually all bacteria, viruses and fungi, and can provide information about drug resistance, virulence and strain type of these pathogens. Commercial applications for the Ibis T5000 Biosensor System include epidemiologic surveillance, monitoring of pandemic diseases, identification of emerging or previously unknown pathogens, forensic characterization of human samples, identification of sources of hospital-associated infections, and, in the future, human infectious disease diagnostics. Ibis develops, manufactures and markets Ibis T5000 instruments and assay kits. Additional information about Ibis can be found by selecting the Ibis link from Isis' homepage at http://www.isispharm.com.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 18 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Ibis Biosciences, Inc., Isis' majority-owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercialization of microRNA therapeutics. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide. Additional information about Isis is available at http://www.isispharm.com.

This release includes forward-looking statements regarding Abbott's investment in Isis' subsidiary, I
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Abbott to Present at Goldman Sachs Global Healthcare Conference
2. Abbott Launches Next-Generation StarClose(R) SE Vascular Closure System
3. Abbott Scientists Present a New Approach for Treating Attention-Deficit Hyperactivity Disorder
4. Abbott Annual Meeting Highlights Outstanding 2007 Results, International Growth and Near-Term Pipeline
5. Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners
6. ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase
7. Smiths Medical to Promote and Distribute Abbotts FreeStyle Navigator Continuous Glucose Monitoring System
8. Abbott to Present at Cowen and Company Health Care Conference
9. Abbott to Present at Lehman Brothers Healthcare Conference
10. Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
11. Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Boston, MA (PRWEB) January 22, 2015 ... systems, is pleased to announce an exciting product from a ... of motion analysis solutions over the past 15 years, with ... industries. Most recently, their 3D IMU system (inertial measurement unit), ...
(Date:1/22/2015)... Diagenode, Inc., a leading global provider ... complete solutions for epigenetics research, recently launched a ... need for manual processing. The new ChIPettor System ... histones or transcription factors and a semi-automated pipette ...
(Date:1/22/2015)... Jan. 22, 2015   GenoSpace , a precision medicine software ... enable the broad use of genomic, imaging and other biomedical ... of Michelle Munson , CEO of Aspera, an IBM ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We are ...
(Date:12/24/2014)... YORK , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. ... critical areas, announced the closing of an underwritten public offering ... up to an aggregate 3,500,000 shares of common stock, at ... warrant.  The warrants have a per share exercise price of ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... - Nearly 40% of Drugs on the Market and 30% of ... ... GPCRs -, HOPKINTON, Mass., May 5 Caliper ... Corporation that enables functional cell-based G protein-coupled,receptor (GPCR) assays from DiscoveRx ...
... Corporation of North,America today announces the immediate appointment ... her new role, Ms. Schwalm will have full,operating ... of Eisai Co., Ltd., Ms. Schwalm brings ... building,high-performing organizations that drive global growth and nearly ...
... CALGARY, May 5 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:,ONC, ... Special Meeting,of the Shareholders will be held on Wednesday, ... Club of New York City, 50 Vanderbilt Ave, New ... Dr. Brad Thompson,President and CEO of Oncolytics, will discuss ...
Cached Biology Technology:Caliper Life Sciences and DiscoveRx Collaborate to Offer Solutions for Cell-Based GPCR Profiling and Lead Optimization 2Caliper Life Sciences and DiscoveRx Collaborate to Offer Solutions for Cell-Based GPCR Profiling and Lead Optimization 3Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President, Eisai Inc. 2Oncolytics Biotech Inc. Announces Details of 2008 Annual Shareholder Meeting 2
(Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... the "Samsung Galaxy S5 - Home Button Synaptics ... http://photos.prnewswire.com/prnh/20130307/600769 ... iPhone 5S, Samsung introduces for the first time a ...
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric data ... industry leaders such as Intel, Jabra, Atlas, and Scosche ... products. These products will be showcased at CES 2015, ... . "Our partners choose PerformTek ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... "Global Facial Recognition Market 2015-2019" report to ... Facial recognition is a technology used for ... overall facial feature of a person such as nose, ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... a powerful new method to investigate the discrete steps necessary ... goes wrong in cancer and other diseases. The finding, based ... 9 issue of Molecular Cell , allows scientists to ... activation. "The new methodology allows us to examine ...
... considered important habitats for marine life, but until recently, ... Researchers from Hawaii Pacific University (HPU) and the Universtiy ... the first extensive study of canyons in the oceanic ... especially abundant and unique communities of megafauna (large animals ...
... Reserve University School of Dental Medicine and School of ... human beta defensin peptide functionproteins important to the peripheral ... environment. They will examine brain tissues to explore ... brain diseases and in particular Alzheimer,s disease (AD). ...
Cached Biology News:Powerful new method allows scientists to probe gene activation 2Hawaiian submarine canyons are hotspots of biodiversity and biomass for seafloor animal communities 2Hawaiian submarine canyons are hotspots of biodiversity and biomass for seafloor animal communities 3Hawaiian submarine canyons are hotspots of biodiversity and biomass for seafloor animal communities 4Searching for brain's defenses to ward off infections, prevent memory loss 2
...
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The 10-user network license entitles ten users to access data f...
Mouse monoclonal antibody raised against a partial recombinant JRKL. NCBI Entrez Gene ID = JRKL...
Mouse monoclonal antibody to ST8SIA2 - ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2...
Biology Products: